✦ LIBER ✦
A New Extended Intestinal Release Formulation of Rifaximin, 400 mg Tablets, for the Treatment of Moderately Active Crohn's Disease
✍ Scribed by Lochs, Herbert ;Prantera, Cosimo ;Gionchetti, Paolo ;Danese, Silvio ;Fogli, Maria Vittoria ;Grimaldi, Maria
- Book ID
- 122227487
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 59 KB
- Volume
- 140
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.